Chronic Liver Disease Mortality Rates Increased During COVID-19 Pandemic
Researchers examined the effects of the COVID-19 pandemic on individuals with nonalcoholic fatty liver disease and alcohol-associated liver disease.
Nonalcoholic Fatty Liver Disease (NAFLD)
Global Prevalence of Nonalcoholic Fatty Liver Disease on the Rise
Researchers sought to estimate the worldwide prevalence and incidence of nonalcoholic fatty liver disease.
Sleep Tied to Metabolic Dysfunction-Associated Fatty Liver Disease
Sleep behaviors are associated with the risk of MAFLD, according to a study published online.
Medical Addiction Therapy Linked to Lower Risk for Alcohol-Associated Liver Disease in Alcohol Use Disorder
Researchers examined whether patients with alcohol use disorder who received medical addiction therapy had a lower risk of developing alcohol-associated liver disease.
Nigella sativa Oil Offers No Cardiometabolic Benefit for Nonalcoholic Fatty Liver Disease
Researchers examined the effects of N sativa oil supplementation on cardiometabolic measures in patients with NAFLD.
Obesity Status and Sex Affect Eating Behavior in Patients With NAFLD
Researchers examined what factors affect eating behaviors in patients with nonalcoholic fatty liver disease.
DASH Diet May Be Protective of Incident Nonalcoholic Fatty Liver Disease Risk
Researchers investigated whether adherence to specific diets were associated with changes in liver fat or incident nonalcoholic fatty liver disease.
Cardiovascular Disease Higher Among Lean Patients With Nonalcoholic Fatty Liver Disease
Researchers sought to determine the prevalence of cardiovascular disease, cirrhosis, metabolic diseases, and chronic kidney disease in lean vs overweight or obese NAFLD.
A Scientific Statement From the AHA on CV Risk in Nonalcoholic Fatty Liver Disease
The American Heart Association has issued a scientific statement regarding the relationship between nonalcoholic fatty liver disease and cardiovascular risk.
Statin Initiation Reduces Risk for Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Researchers examined the association between initiating statin therapy and the risk for HCC in patients with NAFLD.
- Loading...
Loading...
Next post in General Endocrinology
Loading... 
Loading...